Investors Research Corp - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$45
-40.0%
300.0%0.00%
Q4 2022$75300.0%0.00%
Q3 2022$0300.0%0.00%
Q2 2022$0300.0%0.00%
Q1 2022$0300.0%0.00%
Q4 2021$0300.0%0.00%
Q3 2021$0300.0%0.00%
Q2 2021$0300.0%0.00%
Q1 2021$0
-100.0%
300.0%0.00%
Q4 2020$1,000300.0%0.00%
Q3 2020$0300.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders